|
This section will provide you with answers to some of the
questions you may have about our association. It also explains how
to contact us should you want further information
EuropaBio
is the political voice of the biotechnology industry in
Europe. Our
association of bioindustries has some 81 corporate and 5 associate members
operating worldwide, 6 Bioregions and 25 national
biotechnology associations, representing 1800 small and medium
sized biotech companies in Europe.
www.europabio.org
Members of EuropaBio are involved in research, development,
testing, manufacturing and commercialisation of biotechnology
products and processes. Our corporate members have a
wide range of activities: human and animal health care, diagnostics,
bio-informatics, chemicals, crop protection, agriculture, food and
environmental products and services.
EuropaBio also welcomes
associate members such as international commercial, financial, asset
management and other service-providing companies, regional
biotechnology development organisations and scientific institutes.
The common denominator among all our members is the use of
biotechnology at any stage of research, development or
manufacturing.
The benefits of
biotechnology
Biotechnology is one of the most exciting
new sectors to emerge in recent years, offering new ways to treat
and prevent disease and holding the promise of better and cleaner
industrial processes as well as enabling a more sustainable
agriculture to emerge.
In human health, the benefits of biotechnology are evident and
the prospects are bright. Solutions for diseases which so far have
been incurable will in great part be due to the revolution that
biotechnology brings.
In agriculture, biotechnology offers considerably higher yields
and provides alternatives to the use of pesticides. Genetically
modified fruit and vegetables can offer higher nutritional value,
better taste, longer conservation, all to the benefit of the
consumer.
To fight malnutrition in large parts of the developing world and
to feed an ever-growing population, biotechnology offers a safe,
abundant and high quality food supply through a sustainable use of
the world's resources.
Biotechnology is bringing cleaner and greener processes to the
manufacture of detergents and the cleaning up of environmental
waste. Other biotech applications hold the promise of one day
replacing carbon fuels with bio-fuels made from biomass.
New products and new applications emerge every day in
biotechnology and we are confident that our sector has a major
contribution to make in finding new solutions to old problems.
Our industry's ethical
values and behaviour
EuropaBio's Core
Ethical Values Charter is a pledge of responsible behaviour.
We believe that the swift and steady development of science and
technology calls for rapid identification and clarification of the
ethical aspects of this development.
We want to anticipate and explore the impact of change and to
discuss its effects with the scientific community, the public and
their elected representatives.
The Advisory Group on Ethics (AGE) composed of outstanding
independent scholars and researchers provides us with critical
advice. Click here to obtain a copy of EuropaBio's Core Ethical
Values Charter
download pdf
Ensuring safety
The well-being of humans and animals, and the quality of our
environment are the major concerns of any civilised society. They
are fully shared by all of EuropaBio's member companies.
We support authorisation procedures for genetically modified
organisms based on rigorous and science-based safety assessments
that are coherent, transparent and predictable.
We believe that both the scientific community and the industry
should invest enough time and energy to work together with the
public on addressing their concerns.
Europe can take the lead
Scientific,
technological and entrepreneurial skills are there and equity can be
attracted: the future for European biotechnology will be bright if
public acceptance can be won and if the regulatory framework
provides a stable, coherent, transparent and predictable environment
which fosters its development
-
EuropaBio's mission is to promote an innovative and dynamic
biotechnology-based industry in Europe.
-
We advocate free and open markets and the removal of barriers
to competitiveness with other areas of the world.
-
We are committed to an open, informed dialogue with all
stakeholders about the ethical, social and economic aspects of
biotechnology and its applications.
-
We champion the responsible use of biotechnology to ensure
that its potential is fully used to the benefit of humans and
their environment.
Board of Management, sectoral Councils and Working Groups.
EuropaBio has a board of management made up of representatives
from among our members. They are assisted by sectoral councils representing
the main segments of EuropaBio - healthcare (red biotech),
industrial (white biotech), agriculture (green biotech) and emerging
enterprises. Experts from member companies and national associations
actively participate in EuropaBio's working groups which cover a
very wide range of issues and areas of concern to our membership.
EuropaBio's primary
focus is the European Union but because of the global character of
the business, we also represent our members in transatlantic and
worldwide fora.
We are actively engaged in dialogue with the European
institutions and contribute to the creation of a coherent
legislation for bioindustries. EuropaBio ensures a steady flow of
information about biotechnology to the European Parliament, the
European Commission and the Council of Ministers.
Through its member associations, EuropaBio fosters a standing
dialogue with policy makers and stakeholders at a national level and
cooperates with Member State governments, in particular as they
prepare for an EU Presidency term.
Annual Reports
Annual Report 2007
Annual Report 2006
Annual Report 2005
|
About Europabio 
